EMA — authorised 3 June 2022
- Marketing authorisation holder: Roche Registration GmbH
- Status: approved
🇪🇺 Lunsumio in European Union
EMA authorised Lunsumio on 3 June 2022
Marketing authorisation
Lunsumio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lunsumio approved in European Union?
Yes. EMA authorised it on 3 June 2022.
Who is the marketing authorisation holder for Lunsumio in European Union?
Roche Registration GmbH holds the EU marketing authorisation.